ArticleCPT: pharmacometrics & systems pharmacology2023

Population pharmacokinetics and exposure-clinical outcome relationship of remdesivir major metabolite GS-441524 in patients with moderate and severe COVID-19.

Ryo Tamura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.